Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Commentary

  • Countering Breast Cancer's Counterpunch
    Brion W. Murray
    Molecular Cancer Therapeutics Oct 2019, 18 (10) 1682-1683; DOI: 10.1158/1535-7163.MCT-19-0875
  • Stem Cell Factor LIFted as a Promising Clinical Target for Cancer Therapy
    Yu Shi, Sean Hunter, Tony Hunter
    Molecular Cancer Therapeutics Aug 2019, 18 (8) 1337-1340; DOI: 10.1158/1535-7163.MCT-19-0605
  • Precision Medicine: Progress, Pitfalls, and Promises
    Patrick G. Pilié, Patricia M. LoRusso, Timothy A. Yap
    Molecular Cancer Therapeutics Dec 2017, 16 (12) 2641-2644; DOI: 10.1158/1535-7163.MCT-17-0904
  • Mitogen-Activated Protein Kinases Inhibitors: Potential Therapeutic Agents for Cancer Cachexia
    Vickie E. Baracos
    Molecular Cancer Therapeutics Feb 2017, 16 (2) 263-264; DOI: 10.1158/1535-7163.MCT-16-0753
  • The Myb–p300 Interaction Is a Novel Molecular Pharmacologic Target
    Xi Liu, Kathryn A. Gold, Ethan Dmitrovsky
    Molecular Cancer Therapeutics Jun 2015, 14 (6) 1273-1275; DOI: 10.1158/1535-7163.MCT-15-0271
  • Predictive biomarkers for targeting insulin-like growth factor-I (IGF-I) receptor
    Craig P. Carden, L. Rhoda Molife, Johann S. de Bono
    Molecular Cancer Therapeutics Aug 2009, 8 (8) 2077-2078; DOI: 10.1158/1535-7163.MCT-09-0641
  • Liposomal delivery as a mechanism to enhance synergism between anticancer drugs
    Robert J. Lee
    Molecular Cancer Therapeutics Jul 2006, 5 (7) 1639-1640; DOI: 10.1158/1535-7163.MCT-06-C02
  • Apoptosis and anthracycline cardiotoxicity
    Andrew Thorburn, Arthur E. Frankel
    Molecular Cancer Therapeutics Feb 2006, 5 (2) 197-199; DOI: 10.1158/1535-7163.MCT-06-CO1
  • Confirmation and prevention of targeted toxicity by a recombinant fusion toxin
    Robert J. Kreitman
    Molecular Cancer Therapeutics Dec 2004, 3 (12) 1691-1692;
  • Small molecule inhibition of hypoxia inducible factor-1α: A viable therapeutic approach?
    Kenneth D. Tew
    Molecular Cancer Therapeutics Mar 2004, 3 (3) 245-246;

Pages

  • Next
  • 1
  • 2
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement